diseas
caus
novel
betacoronaviru
structur
similar
sarscov
base
structur
syndrom
similar
sarscov
hypothesi
form
potenti
affect
host
metabol
part
lifecycl
hypothesi
evalu
exploratori
analysi
sarscov
human
transcriptom
interact
data
gene
set
enrich
analysi
b
confirmatori
focus
review
literatur
base
find
string
virus
avail
search
human
sarscov
ncbi
taxonomi
id
vs
ncbi
taxonomi
id
genom
interact
reveal
ten
human
protein
interact
sarscov
sgta
phb
jun
gene
set
enrich
analys
gsea
string
network
reveal
role
put
protein
protein
interact
network
ppi
enrich
mediat
viral
parasit
interleukin
well
insulin
signal
diabet
triglycerid
catabol
literatur
sarscov
known
caus
de
novo
diabet
uptak
pancreat
isl
cell
furthermor
dysregul
lipid
autophagi
favor
viral
lifecycl
convers
current
noncaus
observ
evid
wors
outcom
patient
comorbid
diabet
hyperglycemia
studi
report
lipid
profil
patient
howev
lipidtarget
molecul
propos
agent
futur
studi
report
lipid
glucos
metabol
patient
could
help
elucid
diseas
secula
aid
drug
design
caus
novel
betacoronaviru
structur
similar
approxim
sarscov
recent
studi
hoffmann
et
al
similar
sar
virus
extend
depend
host
cell
entri
present
shown
signific
similar
sarscov
clinic
characterist
exploit
host
intracellular
function
due
common
sarscov
remain
attract
substitut
yet
determin
specif
human
protein
interact
consequ
among
first
studi
report
clinic
data
recent
public
yang
colleagu
studi
provid
foundat
hypothesi
put
forth
fang
colleagu
indic
diabet
hypertens
patient
expos
inhibitor
may
increas
risk
sever
metaanalys
sar
cohort
indic
histori
diabet
hyperglycemia
independ
factor
wors
outcom
includ
sever
respiratori
symptom
death
regardless
medic
anoth
studi
sarscov
shown
caus
diabet
infect
pancreat
isl
cell
interestingli
significantli
enrich
camp
signal
pathway
indirect
link
diabet
signal
base
experiment
evid
associ
camp
level
activ
diabet
patient
fals
discoveri
rate
fdr
tabl
follow
entri
host
cell
lipid
metabol
subsequ
import
target
singl
strand
rna
virus
critic
format
viral
envelop
subsequ
lifecycl
autophagi
mediat
triglycerid
lipid
droplet
catabol
one
mechan
identifi
denv
infect
hijack
host
cell
lipid
metabol
shown
critic
step
establish
mer
coronaviru
latenc
sarscov
patient
alter
lipid
metabol
detect
far
year
initi
infect
evid
interplay
diabet
recent
emerg
current
consid
within
context
epidemiolog
studi
determin
diabet
mellitu
dm
frequent
comorbid
furthermor
dm
recent
character
determin
sever
respiratori
syndrom
along
comorbid
asid
dm
novel
hyperglycemia
recent
associ
increas
wors
outcom
patient
howev
associ
independ
predictor
multivari
model
epidemiolog
associ
lipid
metabol
current
possibl
sinc
even
larg
scale
cohort
report
relev
measur
experiment
level
lipid
metabol
cellular
level
propos
treatment
target
specif
interact
sarscov
spike
protein
lipid
rich
membran
compart
well
epigenet
modul
lipid
metabol
consid
endpoint
target
develop
small
molecul
aim
prevent
infect
bar
actual
proteom
sarscov
base
silico
analys
sarscov
human
interact
partial
support
hypothesi
fang
colleagu
insofar
warrant
scrutini
patient
metabol
state
concomit
medic
approach
present
inher
limit
due
set
basi
sarscov
proteom
interact
nevertheless
present
silico
literatur
evid
support
potenti
affect
human
metabol
furthermor
gene
affect
sarscov
infect
significantli
enrich
infect
may
repres
common
interfac
target
virus
futur
studi
determin
interact
effect
human
transcriptom
identifi
drug
target
use
pharmacogenom
enrich
analys
author
confirm
known
conflict
interest
associ
manuscript
financi
support
work
could
influenc
outcom
